Concord Biotech has announced the issuance of a certificate confirming compliance with depositories regulations for the quarter ended December 31, 2024. The certificate, dated January 05, 2026, was provided by MUFG Intime India Private Limited, the Registrar and Share Transfer Agent. The announcement ensures adherence to regulatory requirements regarding dematerialization of securities.
Compliance Confirmation
Concord Biotech has received confirmation regarding compliance with depositories regulations for the quarter ending December 31, 2024. This announcement provides assurance that all security transactions related to dematerialization have been processed according to established guidelines.
Certificate Details
The certificate, issued by MUFG Intime India Private Limited on January 05, 2026, confirms that securities received for dematerialization during the specified quarter were duly processed and confirmed to the depositories. The certificate also states that the securities are listed on the stock exchanges.
Key Points
- Quarter End Date: December 31, 2024
- Certificate Date: January 05, 2026
- Issuer: MUFG Intime India Private Limited
- Confirmation that all requests have been confirmed/rejected.
Source: BSE
